Connect Biopharma reports positive Phase 2 data for COPD drug rademikibart

September 30, 2026 7:00 AM

Connect Biopharma Holdings Limited (Nasdaq: CNTB) reported positive preliminary topline results from its Phase 2 Seabreeze STAT COPD study evaluating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found